SCHEMBL7187700

SCHEMBL7187700

CCOC(=O)N(c1ccccc1)c1ccc(C=O)cc1C=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A3 P47895 3/20 0.39
ALDH1A1 P00352 9/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPT P10636 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TRPM8 Q7Z2W7 2/20 0.37
ALDH3A1 P30838 3/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGIR P43119 1/20 0.35
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7189894 0.92 ALDH1A3 (0.43) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1MAPT
SCHEMBL7194300 0.89 ALDH1A1 (0.41) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1MAPT
SCHEMBL7544197 0.89 CA12 (0.41) CTDSP1ALDH1A3ALDH1A1KMT2AALDH3A1
SCHEMBL7195969 0.86 ALDH1A3 (0.38) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1HSD17B10
SCHEMBL7189902 0.85 CTDSP1 (0.45) CTDSP1SMN1; SMN2ALDH1A1HSD17B10MAPT
SCHEMBL7191758 0.85 CTDSP1 (0.48) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1HSD17B10
SCHEMBL7190159 0.79 ALDH1A3 (0.43) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1MAPT
SCHEMBL7190201 0.78 ALDH1A1 (0.39) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1MAPT
SCHEMBL7542195 0.78 CTDSP1 (0.43) CTDSP1SMN1; SMN2ALDH1A1HSD17B10MAPT
SCHEMBL7196469 0.77 ALDH1A1 (0.41) CTDSP1SMN1; SMN2ALDH1A3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CTDSP1 4808/4885SMN1; SMN2 2971/4885ALDH1A3 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.